F2RL1 and hepatocellular carcinoma: It can be hypothesised that these mechanisms are of importance in the HCC microenvironment where both tumoural and stromal cells may produce PAR2-activating proteinases, like the kallikrein-related peptidases [82, 83] driving PAR2-mediated effects in HSCs on HCC growth.